Regulatory Focus™ > News Articles > IFPMA Releases Updated Code of Ethics for Industry

IFPMA Releases Updated Code of Ethics for Industry

Posted 01 March 2012 | By Alexander Gaffney, RAC 

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) released an updated code of ethics 1 March that aims to broaden the scope of its code of practice to include "interactions with healthcare professionals, medical institutions and patient organizations."

"IFPMA requires all member companies and member associations around the world to adopt and implement this new Code," the organization said in a statement.

IFPMA counts most of the world's top-grossing pharmaceutical manufacturers and prominent organizations amongst its membership.

"[T]he Code now also includes high-level guiding principles for practice, a requirement for member companies to train all employees, a clear distinction between gifts, promotional aids and items of medical utility, guidance for supporting continuing medical education, a provision on disclosure of clinical trials information, and guidance for filing complaints."

Read more:

IFPMA: Expanded Code of Practice for pharmaceutical industry updates ethical and professional standards for interactions with healthcare community

IFPMA Code of Practice 2012

Regulatory Focus newsletters

All the biggest regulatory news and happenings.